Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 10,171 | 14,819 | 20,036 | 11,168 | 10,976 |
| Gross Profit | -10,171 | -14,819 | -20,036 | -11,168 | -10,976 |
| Selling General And Administration | 470,589 | 645,823 | 840,271 | 487,358 | 810,532 |
| General And Administrative Expense | 470,589 | 645,823 | 840,271 | 487,358 | 810,532 |
| Research And Development | 21,838 | 28,020 | 34,434 | 34,560 | 33,742 |
| Operating Expense | 492,427 | 673,843 | 874,705 | 521,918 | 844,274 |
| Operating Income | -502,598 | -688,662 | -894,741 | -533,086 | -855,250 |
| EBIT | -502,598 | -688,662 | -894,741 | -5.7M | -855,250 |
| Interest Income | 28,247 | 26,510 | 15.00 | 456.00 | 261.00 |
| Interest Income Non Operating | 28,247 | 26,510 | 15.00 | 456.00 | 261.00 |
| Net Interest Income | 28,247 | 26,510 | 15.00 | -8,140 | 261.00 |
| Other Income Expense | 72,248 | -56,389 | 172,976 | 3,255 | -41,511 |
| Special Income Charges | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Write Off | -- | -- | -- | -- | 0.00 |
| Gain On Sale Of Security | 72,248 | -56,389 | 172,976 | 3,255 | -41,511 |
| Pretax Income | -402,103 | -718,541 | -721,750 | -537,971 | -896,500 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -402,103 | -718,541 | -721,750 | -537,971 | -896,500 |
| Net Income From Continuing Operation Net Minority Interest | -402,103 | -718,541 | -721,750 | -537,971 | -896,500 |
| Net Income Including Noncontrolling Interests | -402,103 | -718,541 | -721,750 | -537,971 | -896,500 |
| Net Income Common Stockholders | -402,103 | -718,541 | -721,750 | -537,971 | -896,500 |
| Net Income | -402,103 | -718,541 | -721,750 | -537,971 | -896,500 |
| EBITDA | -492,427 | -673,843 | -874,705 | -5.7M | -844,274 |
| Normalized EBITDA | -564,675 | -617,454 | -1.0M | -5.7M | -802,763 |
| Reconciled Depreciation | 10,171 | 14,819 | 20,036 | 11,168 | 10,976 |
| Basic EPS | 0.00 | -0.01 | -0.01 | -- | -0.01 |
| Diluted EPS | 0.00 | -0.01 | -0.01 | -- | -0.01 |
| Basic Average Shares | 136.5M | 124.4M | 124.0M | -- | 108.1M |
| Diluted Average Shares | 136.5M | 124.4M | 124.0M | -- | 108.1M |
| Total Unusual Items | 72,248 | -56,389 | 172,976 | 3,255 | -41,511 |
| Total Unusual Items Excluding Goodwill | 72,248 | -56,389 | 172,976 | 3,255 | -41,511 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -474,351 | -662,152 | -894,726 | -541,226 | -854,989 |
| Diluted NI Availto Com Stockholders | -402,103 | -718,541 | -721,750 | -537,971 | -896,500 |
| Gain On Sale Of Ppe | -- | -- | -- | 0.00 | 0.00 |
| Impairment Of Capital Assets | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Net Income Continuous Operations | -402,103 | -718,541 | -721,750 | -537,971 | -896,500 |
| Net Non Operating Interest Income Expense | 28,247 | 26,510 | 15.00 | -8,140 | 261.00 |
| Other Gand A | 140,644 | 295,916 | 192,175 | 249,600 | 262,805 |
| Reconciled Cost Of Revenue | 10,171 | 14,819 | 20,036 | 11,168 | 10,976 |
| Salaries And Wages | 329,945 | 349,907 | 648,096 | 237,758 | 547,727 |
| Total Expenses | 502,598 | 688,662 | 894,741 | 533,086 | 855,250 |
| Total Operating Income As Reported | -430,350 | -745,051 | -721,765 | -538,427 | -896,761 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 9.6M | 302,391 | 1.3M | 1.2M | 2.6M |
| Cash Cash Equivalents And Short Term Investments | 9.6M | 302,391 | 1.3M | 1.2M | 2.6M |
| Cash Financial | -- | -- | -- | 1.2M | -- |
| Accounts Receivable | 29,840 | 49,070 | 40,920 | 31,829 | 23,568 |
| Receivables | 29,840 | 49,070 | 40,920 | 31,829 | 23,568 |
| Prepaid Assets | 295,967 | 150,004 | 100,745 | 113,159 | 74,114 |
| Current Assets | 10.0M | 501,465 | 1.4M | 1.3M | 2.7M |
| Gross PPE | -- | -- | -- | 12.0M | -- |
| Accumulated Depreciation | -- | -- | -- | -81,432 | -- |
| Net PPE | 13.7M | 13.2M | 12.3M | 12.0M | 10.4M |
| Total Non Current Assets | 13.7M | 13.2M | 12.3M | 12.0M | 10.4M |
| Total Assets | 23.7M | 13.7M | 13.8M | 13.3M | 13.0M |
| Current Debt And Capital Lease Obligation | 31,329 | 29,938 | -- | 13,607 | 19,946 |
| Accounts Payable | 168,969 | 319,291 | 288,014 | 445,781 | -- |
| Payables | 168,969 | 319,291 | 288,014 | 445,781 | -- |
| Payables And Accrued Expenses | 168,969 | 319,291 | 288,014 | 445,781 | 207,600 |
| Current Liabilities | 200,298 | 349,229 | 288,014 | 459,388 | 227,546 |
| Long Term Debt And Capital Lease Obligation | 51,152 | 60,785 | 4,674 | -- | -- |
| Long Term Capital Lease Obligation | 51,152 | 60,785 | 4,674 | 0.00 | 0.00 |
| Total Non Current Liabilities Net Minority Interest | 51,152 | 60,785 | 4,674 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 251,450 | 410,014 | 292,688 | 459,388 | 227,546 |
| Common Stock | 41.4M | 30.9M | 30.7M | 29.8M | 29.1M |
| Capital Stock | 41.4M | 30.9M | 30.7M | 29.8M | 29.1M |
| Retained Earnings | -22.4M | -22.0M | -21.2M | -20.5M | -20.0M |
| Gains Losses Not Affecting Retained Earnings | 4.3M | 4.3M | 4.0M | 3.6M | 3.7M |
| Common Stock Equity | 23.4M | 13.3M | 13.5M | 12.8M | 12.8M |
| Stockholders Equity | 23.4M | 13.3M | 13.5M | 12.8M | 12.8M |
| Total Equity Gross Minority Interest | 23.4M | 13.3M | 13.5M | 12.8M | 12.8M |
| Total Capitalization | 23.4M | 13.3M | 13.5M | 12.8M | 12.8M |
| Net Tangible Assets | 23.4M | 13.3M | 13.5M | 12.8M | 12.8M |
| Tangible Book Value | 23.4M | 13.3M | 13.5M | 12.8M | 12.8M |
| Working Capital | 9.8M | 152,236 | 1.1M | 875,587 | 2.4M |
| Invested Capital | 23.4M | 13.3M | 13.5M | 12.8M | 12.8M |
| Total Debt | 82,481 | 90,723 | 4,674 | 13,607 | 19,946 |
| Share Issued | 155.5M | 125.2M | 124.2M | 121.4M | 119.8M |
| Ordinary Shares Number | 155.5M | 125.2M | 124.2M | 121.4M | 119.8M |
| Capital Lease Obligations | 82,481 | 90,723 | 4,674 | 13,607 | 19,946 |
| Current Capital Lease Obligation | 31,329 | 29,938 | -- | 13,607 | 19,946 |
| Other Properties | -- | -- | -- | 12.0M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -478,747 | -17,795 | -451,536 | -561,333 | -196,780 |
| Cash Flow From Continuing Operating Activities | -478,747 | -17,795 | -451,536 | -561,333 | -196,780 |
| Depreciation And Amortization | 10,171 | 14,819 | 20,036 | 11,168 | 10,976 |
| Depreciation Amortization Depletion | 10,171 | 14,819 | 20,036 | 11,168 | 10,976 |
| Stock Based Compensation | 208,186 | 231,272 | 532,151 | 120,137 | 483,757 |
| Change In Working Capital | -282,149 | 440,442 | -276,032 | -111,116 | 214,016 |
| Change In Receivables | -126,733 | -57,409 | -16,642 | -27,340 | 117,033 |
| Change In Payables And Accrued Expense | -155,416 | 497,851 | -279,356 | -63,810 | 96,983 |
| Other Non Cash Items | 2,142 | 819.00 | 273.00 | 0.00 | 666.00 |
| Capital Expenditure | -518,039 | -1.2M | -256,969 | -1.3M | -486,810 |
| Purchase Of PPE | -518,039 | -1.2M | -256,969 | -1.3M | -486,810 |
| Net PPE Purchase And Sale | -518,039 | -1.2M | -256,969 | -1.3M | -486,810 |
| Investing Cash Flow | -518,039 | -1.2M | -256,969 | -1.3M | -486,810 |
| Cash Flow From Continuing Investing Activities | -518,039 | -1.2M | -256,969 | -1.3M | -486,810 |
| Repayment Of Debt | -11,540 | -5,579 | -8,370 | -1.00 | -8,370 |
| Net Issuance Payments Of Debt | -11,540 | -5,579 | -8,370 | -1.00 | -8,370 |
| Issuance Of Capital Stock | -- | -- | -- | 0.00 | 3.3M |
| Net Common Stock Issuance | -- | -- | -- | 0.00 | 3.3M |
| Financing Cash Flow | 10.3M | 266,921 | 812,880 | 433,098 | 3.1M |
| Cash Flow From Continuing Financing Activities | 10.3M | 266,921 | 812,880 | 433,098 | 3.1M |
| Changes In Cash | 9.3M | -991,971 | 104,375 | -1.4M | 2.5M |
| Beginning Cash Position | 302,391 | 1.3M | 1.2M | 2.6M | 114,993 |
| End Cash Position | 9.6M | 302,391 | 1.3M | 1.2M | 2.6M |
| Free Cash Flow | -996,786 | -1.3M | -708,505 | -1.8M | -683,590 |
| Asset Impairment Charge | 0.00 | -- | -- | 0.00 | 0.00 |
| Change In Prepaid Assets | 0.00 | 0.00 | 19,966 | -19,966 | 0.00 |
| Common Stock Issuance | -- | -- | -- | 0.00 | 3.3M |
| Depreciation | 10,171 | 14,819 | 20,036 | 11,168 | 10,976 |
| Gain Loss On Sale Of PPE | -- | -- | -- | 0.00 | 0.00 |
| Long Term Debt Payments | -11,540 | -5,579 | -8,370 | -1.00 | -8,370 |
| Net Foreign Currency Exchange Gain Loss | -14,994 | 13,394 | -6,214 | -43,551 | 1,305 |
| Net Income From Continuing Operations | -402,103 | -718,541 | -721,750 | -537,971 | -907,500 |
| Net Long Term Debt Issuance | -11,540 | -5,579 | -8,370 | -1.00 | -8,370 |
| Net Other Financing Charges | -- | -- | -- | -19,401 | -- |
| Operating Gains Losses | -14,994 | 13,394 | -6,214 | -43,551 | 1,305 |
| Proceeds From Stock Option Exercised | 4.3M | 272,500 | 821,250 | 452,500 | 0.00 |